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Synergistic effect of interleukin-1 and CD40L on the activation It has been proposed that the progressive loss of kid-
of human renal tubular epithelial cells. ney function observed in many renal diseases results
Background. Renal tubular epithelial cells are a central cell from a pathogenic process that is independent of the
type in tubulointerstitial inflammation because they can pro-
original cause, functioning as a final common pathwayduce inflammatory mediators such as cytokines and chemo-
[1]. This common pathway is characterized by the trig-kines. Several signals derived from either monocytes or acti-
gering of interstitial infiltration and the induction of tu-vated T cells have been reported to regulate the activation of
tubular epithelial cells. We studied this regulation in more bular damage. Indeed, the decline of renal function is
detail by combined treatment with CD40 ligand and the proin- associated with mononuclear cell infiltration in the inter-
flammatory cytokine interleukin-1 (IL-1) in vitro. stitium, tubular atrophy, and interstitial fibrosis [2]. TheMethods. The regulation of cytokine and chemokine pro-
interstitial infiltrate consists of both monocytes/macro-duction was studied in primary cultures of human proximal
phages and T lymphocytes, with CD41 cells generallytubular epithelial cells (PTECs). PTECs were activated by co-
culture with CD40L-transfected murine fibroblasts in combina- being more prominent than CD81 cells. Infiltrating T
tion with recombinant human cytokines. The production of cells and monocytes supply the local environment with
IL-6, IL-8, monocyte chemoattractant protein-1 (MCP-1), and a wide variety of cytokines that regulate numerous
RANTES were measured by specific enzyme-linked immuno- pathophysiological processes, including inflammation [1,sorbent assay.
3, 4].Results. The combined activation of PTECs with CD40L
Resident renal cells, such as tubular epithelial cells,and IL-1 resulted in strong synergistic effects on the production
of IL-6, IL-8, and RANTES, whereas only an additive stimula- might also have an important role in the inflammatory
tion of MCP-1 production was observed. The effects were spe- response. In vitro studies of human tubular epithelial
cific for IL-1 and could be neutralized by the addition of the cells have demonstrated that these cells can produce
IL-1R antagonist. Both IL-1a and IL-1b showed similar effects
large amounts of cytokines [interleukin-6 (IL-6) andon cytokine production by PTECs. The effects of IL-1 were
tumor necrosis factor-a (TNF-a)] [5–7], chemokinesdose dependent, and kinetic experiments showed that syner-
[IL-8, monocyte chemoattractant protein-1 (MCP-1),gistic effects were observed after 24 hours of activation and
remained present for at least five days. Reverse transcription- RANTES, and ENA-78] [8–14], and complement com-
polymerase chain reaction analysis showed that human PTECs ponents (C3, C4, factor-B) [15–17]. Therefore, tubular
could express both IL-1a and IL-1b. The activation of PTECs epithelial cells might be considered as a central cell type
with IL-1 resulted in an up-regulation of CD40 expression on
in the renal inflammatory response, which contributesthese cells.
to the regulation of interstitial infiltration via the produc-Conclusions. A complex network of regulation exists for
the production of cytokines and chemokines by PTECs. The tion of chemokines [18].
combined treatment results in strong synergistic effects on IL-6, Previous studies have shown that the production of
IL-8, and RANTES production. This strengthens the potential most inflammatory mediators by PTECs can be stimu-
role of tubular epithelial cells in inflammatory responses within lated by the proinflammatory cytokines IL-1 and TNF-a.the kidney.
Of these mediators, IL-1 was the most active. IL-1 is
a cytokine with a wide range of proinflammatory and
immunological effects, including activation of endothe-Key words: cytokines, chemokines, CD40, inflammation, tubulointer-
stitial disease, progressive renal disease. lial cells, stimulation of T and B lymphocytes, increased
production of cytokines and chemokines, and increasedReceived for publication August 19, 1998
leukocyte adhesion [19]. There are two distinct molecu-and in revised form January 19, 1999
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specific IL-1 receptors. Next to activated monocytes/ was confirmed by morphological appearance and immu-
nofluorescence staining (CD26 positive), as describedmacrophages, many other cells may serve as a source of
IL-1 production [19]. The increased expression of IL-1 [16, 31]. Primary cell lines were used for experiments
between passages 2 and 7 of culture.in the kidney has been demonstrated in various forms
of both human and experimental glomerulonephritis L cells. The generation of mouse fibroblast L cells
stably transfected with the complete human CD40L cod-[20–24]. Furthermore, the treatment with agents that
neutralize IL-1, such as the natural IL-1R antagonist (IL- ing sequence has been previously described [32]. Non-
transfected cells were used as a negative control. BothRA), blunts the inflammatory processes in various forms
of experimental glomerulonephritis [25–27]. These data types of L cells were cultured in IMDM glutamax
(GIBCO/Life Technologies) supplemented with 10%suggest a causal role for IL-1 in renal inflammation, with
activation of resident kidney cells, such as PTECs, as a heat-inactivated FCS and penicillin/streptomycin (GIB-
CO/Life).possible mechanism.
Recently, we demonstrated the expression of a func-
Culture and activation experimentstional CD40 receptor on the surface of renal epithelial
cells [13]. The ligand for this receptor is CD40L (CD154), For induction of cytokine production, PTECs were
trypsinized and seeded in complete DMEM/Ham-F12which is mainly expressed on activated CD41 T cells.
The interaction between CD40 and CD40L plays a piv- medium in a volume of 1 ml and in a final PTEC concen-
tration of 1 3 105 cells in 24-well plates. PTECs wereotal role in immune regulation [28]. In vitro cross-linking
of the CD40 receptor on tubular epithelial cells resulted activated with recombinant human cytokines at the fol-
lowing final concentrations: IL-1a (1 ng/ml), IL-1bin a strongly increased production of the chemokines
IL-8 and MCP-1 [13]. Interestingly, a strong production (1 ng/ml), TNF-a (15 ng/ml), IL-4 (10 ng/ml), and IL-10
(10 ng/ml) unless indicated otherwise. IL-1 and TNF-aof RANTES was also induced by this single CD40L
stimulus. This seems in contrast to activation of PTECs cytokines were obtained from Genzyme (Uden, the
Netherlands), and IL-4 and IL-10 were a kind gift of Dr.with cytokines, where a combination of at least two cyto-
kines [IL-1 1 interferon-g (IFN-g) or TNF-a 1 IFN-g] F. Briere (Schering Plough, Dardilly, France). Superna-
tants were harvested after 72 hours of culture and wereseems to be required [29].
It is anticipated that under inflammatory conditions, frozen prior to analysis of cytokine production.
For simultaneous CD40 activation, trypsinized PTECsactivated T cells will express CD40L and secrete cyto-
kines. Also, infiltrating monocytes will contribute to the and trypsinized L cells were mixed in suspension in a
1:1 ratio, as described before [13]. Cells were culturedlocal production of proinflammatory cytokines. There-
fore, we have investigated the combined activation of in complete DMEM/Ham F12 medium in a volume of
1 ml and in a final PTEC concentration of 1 3 105 cells/PTECs in vitro using both CD40L and the proinflamma-
tory cytokine IL-1. ml. L cells were irradiated (80 Gy) to prevent overgrowth
of the cultures. Experiments with B lymphocytes have
shown that irradiation does not inhibit the CD40L acti-
METHODS
vating capacity [32, 33]. Supernatants were harvested
Cell cultures after 72 hours of culture, unless indicated otherwise, and
were frozen prior to analysis of cytokine production.Proximal tubular epithelial cells. Primary human PTEC
lines were cultured from cortex tissue of human kidneys To investigate the specificity of the IL-1 effects, cul-
tures were performed in the presence of recombinantnot suitable for transplantation because of anatomical
reasons or from healthy parts of nephrectomy specimens IL-1RA at a concentration of 120 ng/ml (a kind gift
of Dr. A. Steinkasserer, University of Oxford, Oxford,[30]. PTEC monolayers were cultured on a matrix of
collagen type I (Sigma Chemical Co., St. Louis, MO, UK) [34].
USA) and heat-inactivated fetal calf serum (FCS; Life
Determination of cytokine productionTechnologies Inc., Gaithersburg, MD, USA), in a selec-
tive medium, consisting of a 1:1 ratio of Dulbecco’s modi- The production of cytokines by cultured epithelial
cells was measured in the culture supernatants by immu-fied Eagle’s medium (DMEM) and Ham-F12 (both from
Seromed Biochem KG, Berlin, Germany), supple- noassays specific for human cytokines. Details on the
measurement of IL-6 [35], IL-8 [9], MCP-1 [10], andmented with insulin (5 mg/ml), transferrin (5 mg/ml),
selenium (5 ng/ml), hydrocortisone (36 ng/ml), tri-iodo- RANTES [13] have been described in previous reports.
The stimulation index of the different stimuli (cyto-thyronine (40 pg/ml), and epidermal growth factor (10
ng/ml; all from Sigma). For passage of the cultures, cells kines, CD40L, combinations) on different cytokine pro-
ductions was calculated as the ratio of the productionwere harvested by trypsinization with 0.02% (wt/vol)
ethylenediaminetetraacetic acid (EDTA)/0.05% (wt/ in the presence of this stimulus divided by the basal
production in the absence of this stimulus.vol) trypsin (Sigma). The specific outgrowth of PTECs
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Table 1. Sequence of primers used for RT-PCR
Gene Primer Size Reference
b-actin Forward 527 [62]
59-CTACAATGAGCTGCGTGTGG-39
Reverse
59-AAGGAAGGCTGGAAGAGTGC-39
IL-1a Forward 600 [63]
59-ATGGCCAAAGTTCCAGACATGTTT-39
Reverse
59-GTGACTGCCCAAGATGAAGACCAA-39
IL-1b Forward 777 [63]
59-ATGATGGCTTATTACAGTGGCAAT-39
Reverse
59-TTCACCATGCAATTTGTGTCTTCC-39
RNA isolation and reverse transcription-polymerase vested with 2.5 mm EDTA in PBS to prevent proteolysis
of the surface receptors. The whole staining procedurechain reaction analysis
was performed in staining buffer containing 1% BSAFor polymerase chain reaction (PCR) analysis of
(Sigma), 1% human serum, and 0.02% sodium azide ingrowing cells, total RNA was isolated using RNAzol
PBS. CD40 antibody (mAb89) was added in a final con-(Campro, Veenendaal, the Netherlands), a method bas-
centration of 5 mg/ml, incubated for 30 minutes, washeded on the guanidium chloride isolation [36], according
three times with staining buffer, followed by incubationto manufacturer’s instructions. The quantity and purity
with a secondary antibody goat-antimouse Ig-PE (Dako,of RNA preparations were determined by measuring
Glostrup, Denmark). Cell fluorescence was measured onthe outer diameter (OD) at 260 and 280 nm. In these
a FACScan (Becton Dickinson, Mountain View, CA,experiments, PTECs were activated with a soluble chi-
USA), and data were analyzed with the LYSIS program.meric protein consisting of the extracellular parts of mu-
rine CD8 and human CD40L [32]. This protein allows the
Statistical analysisactivation of CD40 without the introduction of another
Data on the stimulation of cytokine production in-source of mRNA.
duced by CD40L or different cytokines were analyzedFixed amounts of total cellular RNA (1 mg) were re-
by the two-tailed Student’s t-test. P values of less thanverse transcribed into cDNA by oligo-dT priming using
0.05 were considered statistically significant.M-MLV reverse transcriptase (RT; GIBCO/Life Tech-
To determine whether combined stimulation withnologies). The amplification of cDNA by PCR was per-
CD40L and cytokines resulted in synergistic effects, indi-formed using the primers as described in Table 1. PCR
ces of synergy were determined (that is, the quotient ofamplification was performed under standard conditions
the cytokine production after costimulation and the sum[50 mm KCl, 10 mm Tris-HCl, pH 8.4, 2 mm MgCl2, 0.06
of the cytokine productions after single stimulation). Themg/ml bovine serum albumin (BSA), 0.25 mm dNTPs,
Wilcoxon matched-pairs signed-ranks test was used, and25 pmol of each primer, and 1 U of Taq polymerase;
costimulatory effects were considered significantly syner-Perkin Elmer, Norwalk, CT, USA] by 35 cycles of the
gistic when indices of synergy are above 1 and when Pfollowing scheme: 1.5 minutes at 958C, 2.5 minutes at
values are less than 0.05.608C, and 1.5 minutes at 728C, followed by 10 minutes
of primer extension at 728C.
Polymerase chain reaction products were analyzed on
RESULTSa 1% agarose gel containing ethidium bromide. Final
Interleukin-6 production by proximal tubularresults were registered using the Eagle eye (Stratagene,
epithelial cells after simultaneous activationSan Diego, CA, USA), and for reasons of clarity, the
by CD40L and cytokinesimages were black/white inverted.
We studied in detail the activation of PTECs by mono-
Fluorescent activated cell sorter staining cyte/macrophage- and T-cell–derived signals. Human
primary PTECs were stimulated either by cytokinesFor fluorescent activated cell sorter (FACS) analysis,
PTECs were cultured in the absence or presence of 1 alone (proinflammatory cytokines IL-1a and TNF-a;
anti-inflammatory cytokines IL-4 and IL-10) or by com-ng/ml IL-1a. After 48 hours, the cells were harvested,
and CD40 expression was determined. PTECs were har- binations of these cytokines with CD40L. Both IL-1a
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Fig. 1. Effect of cytokines in combination
with CD40L on interleukin-6 (IL-6) produc-
tion by proximal tubular epithelial cells
(PTECs). PTECs (105 cells/ml) were cultured
as described in the Methods section. Cells
were cocultured with either nontransfected
(A) or CD40L-transfected (B) L cells (105
cells/ml), as indicated. In addition, cells were
activated with recombinant human cytokines:
IL-1a, IL-4, IL-10, or tumor necrosis factor-a
(TNF-a). After 72 hours, supernatants were
harvested and tested for IL-6 production by
specific enzyme-linked immunosorbent assay
(ELISA). Data indicated are representative of
experiments with seven different PTEC lines,
and shown are the mean production (6 sd)
of duplicate cultures. *P , 0.05 compared with
medium (A) or to CD40L (B).
and TNF-a increased IL-6 production by PTECs (Fig. RANTES production (Fig. 2E), whereas activation with
1A), which is in accordance with previous publications CD40L did result in significant RANTES production, as
[5, 6]. In addition, stimulation with CD40L also increased published before [13]. A combination of CD40L with IL-
IL-6 production. Compared with basal IL-6 production, 1a or TNF-a resulted in a strongly increased RANTES
a mean 21.6-fold stimulation by IL-1a, a 4.9-fold stimula- production (Fig. 2F and Table 2). Although IL-4 showed
tion by TNF-a, and a 5.1-fold stimulation by CD40L no effect on the CD40L-induced IL-6, IL-8, or MCP-1
were found in seven independent experiments. However, production by PTECs, it strongly increased RANTES
when combined with CD40L, only IL-1a and not TNF-a production, as shown recently [37].
showed a strong synergy in the augmentation of IL-6
production (Fig. 1B). Combined treatment resulted in a Effects of interleukin-1 are inhibited by
mean 143.2-fold (CD40L/IL-1a) and 9.5-fold (CD40L/ interleukin-1RA
TNF-a) stimulation, respectively. No effects were found
In view of the strong stimulatory effects of combina-of IL-4 or IL-10 on IL-6 production by PTECs, either
tions of CD40L and IL-1a, we focused on the IL-1awhen tested alone or in combination with CD40L
effect. To confirm the specificity of the observed IL-1a(Fig. 1B).
effects, we used a recombinant form of the natural IL-
Chemokine production by proximal tubular epithelial 1RA. The addition of IL-1RA completely neutralized
cells after simultaneous CD40L and the effects of exogenous IL-1a on the CD40L-induced
cytokine activation production of IL-6 (Fig. 3A), IL-8 (Fig. 3B), MCP-1
To investigate whether the observed effects were spe- (Fig. 3C), and RANTES (Fig. 3D). In all cases, cytokine
cific for IL-6 production, we also investigated the produc- production is reverted to the levels induced by CD40L
tion of the chemokines IL-8, MCP-1, and RANTES, alone. IL-1RA also completely neutralized the effects
which are known to be produced by PTECs. Comparable of exogenous IL-1a in the absence of CD40L, and no
with the regulation of IL-6 production, again both IL- effects of the IL-1RA are seen on the basal cytokine
1a, TNF-a, and CD40L showed an increase in IL-8 pro- production by in vitro cultured PTECs (data not shown).
duction, whereas only IL-1a showed a strong synergy
when combined with CD40L (Fig. 2 A, B). The mean Both interleukin-1a and interleukin-1b have synergy
stimulation indices of seven independent experiments with CD40L
are given in Table 2.
Interleukin-1 consists as two molecular forms (IL-1aInterestingly, differences in the regulation of MCP-1
and IL-1b), with overlapping biological activities. Weand RANTES production were found. For MCP-1, again
tested the effect of both recombinant IL-1a and IL-IL-1a, TNF-a, and CD40L showed a stimulation of pro-
1b on the activation of PTECs. Both molecular formsduction by PTECs. However, in contrast to the produc-
showed a similar induction of IL-6 production by PTECs,tion of IL-6 and IL-8, the combined activation with
and both were able to cooperate with CD40L stimulationCD40L and IL-1a only resulted in additive effects (Fig.
(Fig. 4). In addition, the effects of exogenous IL-1b were2, C, D and Table 2).
also completely neutralized by the addition of the IL-The treatment of PTECs with single cytokines (IL-1a,
TNF-a, IL-4, and IL-10) did not result in detectable 1RA (data not shown).
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Fig. 2. Effect of cytokines in combination
with CD40L on interleukin-8 (IL-8), mono-
cyte chemoattractant protein-1 (MCP-1), and
RANTES production by proximal tubular epi-
thelial cells (PTECs). PTECs (105 cells/ml)
were cocultured with either nontransfected
(A, C, E) or CD40L-transfected (B, D, F ) L
cells (105 cells/ml), as described in Figure 1.
After 72 hours, supernatants were harvested
and tested for IL-8 (A, B), MCP-1 (C, D),
and RANTES (E, F) production by specific
enzyme-linked immunosorbent assay. Data
indicated are representative of experiments
with seven different PTEC lines, and shown
are the mean production (6 sd) of duplicate
cultures. Note that the figures shown for IL-
6, IL-8, MCP-1, and RANTES production are
obtained from different experiments with dif-
ferent PTEC lines. *P , 0.05 compared with
medium (A) or to CD40L (B). In all cases,
CD40L stimulation was also significant com-
pared with medium.
Dose- and time-dependent increase in interleukin-6
production by proximal tubular epithelial cells after
stimulation with CD40L and interleukin-1aTable 2. Index of stimulation of IL-6, IL-8, MCP-1 and RANTES
production by human PTEC We tested the dose of IL-1a necessary to stimulate
IL-6 production by PTECs. A significant increase, com-Mean fold increase over baseline
pared with background production, was found with 50IL-6 IL-8 MCP-1 RANTESa
pg/ml of IL-1a, and increasing amounts of IL-1a showed
Medium 1.0 1.0 1.0 1.0a
a dose-dependent increase in IL-6 production (Fig. 5).IL-1 21.6 17.9 4.5 1.0a
IL-4 1.1 0.6 0.8 1.0a In combination with CD40L, production levels of IL-6
IL-10 1.2 0.6 1.4 1.0a were higher, but the dose response kinetics remainedTNF-a 4.9 1.9 6.0 1.0a
the same. Logarithmic presentation of the production
CD40L 5.1 3.0 6.5 59 levels on the y-axis revealed that the lines were parallel,CD40L IL-1 143.2b 113.3b 9.8 354b
suggesting that the dose response of IL-1 is independentCD40L IL-4 4.5 1.9 6.0 396b
CD40L IL-10 4.0 3.0 8.2 53 of the CD40L stimulation. Similar dose response curves
CD40L TNF-a 9.5 5.8 10.7 107b were found for the chemokines IL-8, MCP-1, and
a Stimulation of PTEC with cytokines alone does not result in detectable RANTES (data not shown).RANTES production. For calculation of the stimulation index, we have therefore
used the detection limit of the RANTES ELISA (0.1 ng/ml). Data included are Next, we investigated the time relationship between
the mean of seven independent experiments. IL-6 production and CD40L and/or IL-1 stimulation.b P , 0.05 synergistic effects in combination with CD40L as determined by
the Wilcoxon matched-pairs signed-ranks test. Supernatants were harvested at various time points as
indicated. Already after 24 hours of culture, the syner-
gistic effect between IL-1a and CD40L on IL-6 produc-
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Fig. 3. Interleukin (IL)-1a–induced effects on cytokine production are completely inhibited by recombinant IL-1R antagonist. PTECs (105 cells/
ml) were cultured as described and were activated with IL-1a (1 ng/ml) and/or CD40L as indicated. Recombinant IL-1R antagonist was added at
the beginning of the cultures at a concentration of 120 ng/ml. After 72 hours, supernatants were harvested and tested for IL-6 (A), IL-8 (B),
MCP-1 (C), and RANTES (D) production. Data indicated are representative of experiments with three different PTEC lines, and shown are the
mean production (6 sd) of duplicate cultures. *P , 0.05 effect of IL-1RA on CD40L 1 IL-1 induced production; NS is not significant.
Fig. 4. Both IL-1a and IL-b stimulate IL-6 production by PTECs.
PTECs were cocultured with either nontransfected or CD40L-trans-
fected L cells (105 cells/ml), as indicated. In addition, cells were activated
with recombinant human IL-1a or IL-1b (both at 1 ng/ml). After 72 Fig. 5. Dose-dependent effects of IL-1a on IL-6 production by PTECs.
hours, supernatants were harvested and tested for IL-6 production PTECs (105 cells/ml) were cultured as described and were activated
by specific enzyme-linked immunosorbent assay. Data indicated are with increasing concentrations of IL-1a in the absence (s) or presence
representative of experiments with three different PTEC lines, and (d) of CD40L stimulation. After 72 hours, supernatants were harvested
shown are the mean production (6 sd) of duplicate cultures. *P , 0.05 and tested for IL-6 production. Data indicated are representative of
compared with medium or **P , 0.05 compared with CD40L. experiments with four different PTEC lines, and shown are the mean
production (6 sd) of duplicate cultures.
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DISCUSSION
In this study, we found a strong stimulatory effect of
combinations of CD40L and IL-1 on the production of
IL-6, IL-8, MCP-1, and RANTES by primary cultures
of human PTECs. Increased production of these media-
tors in situ may contribute to local inflammatory re-
sponses in the renal interstitium. The different chemo-
kines (IL-8, MCP-1, and RANTES) exert preferential
chemoattractant effects on different cell types: IL-8 is a
chemoattractant for neutrophils. MCP-1 is a chemoat-
tractant for monocytes, and RANTES is a chemoattrac-
tant for T cells [18, 38]. Therefore, differential regulation
of the various chemokines will have a direct impact on
Fig. 6. Kinetics of IL-6 production by PTEC after stimulation with IL- the composition of the cellular infiltrate. These results
1a and/or CD40L. PTECs (105 cells/ml) were cultured as described in underline the potential importance of the PTECs as reg-
the Methods section, and were activated with IL-1a in the absence or
ulators of local inflammation. Interestingly, the syner-presence of CD40L stimulation. Supernatants were harvested at the
indicated time points and were tested for IL-6 production. Data are gistic effects were specifically observed for combinations
representative of experiments with three different PTEC lines, and of IL-1 and CD40L and were not found with combina-shown are the mean production (6 sd) of duplicate cultures. Symbols
tions of CD40L and TNF-a, another major proinflam-are: (h) med; (s) IL-1; (m) CD40L; (d) IL-1 1 CD40L.
matory cytokine. However, because CD40L and TNF-a
belong to the same superfamily of ligands [39], it might
be that these two factors induce overlapping sets of signal
transduction pathways.tion could be observed (Fig. 6). Production levels in-
These data show an intimate interplay between IL-1creased in time and reached a plateau level at 72 to 96
and CD40L in vitro. We found not only a strong synergyhours and remained stable until 144 hours.
between IL-1 and CD40L on cytokine production by
PTECs, but also an induction of IL-1a message byExpression of interleukin-1a and interleukin-1b by
PTECs after CD40L activation and increased CD40 ex-proximal tubular epithelial cells
pression on PTECs after IL-1 activation. Previous studiesSome immunohistochemical studies have suggested
have described the cooperation between IL-1 andthat PTECs are a possible source of IL-1 production
CD40L. The combination of CD40L and IL-1 results in[20, 23, 24]. Therefore, we performed RT-PCR analysis
an increased granulocyte macrophage-colony stimulat-using specific primers for IL-1a and IL-1b (Table 1). We
ing factor (GM-CSF) production by thymic epithelialused cDNA from nonstimulated or CD40L-stimulated
cells [40], increased GM-CSF and MIP-1a production byPTECs. Semiquantitative RT-PCR for b-actin confirmed
synoviocytes [41], and an increased leukemia inhibitorythat equal quantities of cDNA have been generated (Fig.
factor (LIF) production by endothelial cells [42]. How-7A). Under both conditions, expression of IL-1b mRNA
ever, these studies did not reveal the strong synergy aswas observed. Interestingly, although absent in nonstim-
observed with PTECs. In addition, using peripheral
ulated PTECs, after activation with CD40L expression
blood monocytes, CD40L stimulation increases IL-1 pro-
of IL-1a mRNA also could be observed (Fig. 7B).
duction by monocytes [43–45], which could be down-
regulated by IL-4 and IL-10 [46]. Like on PTECs, IL-1Interleukin-1 increases CD40 expression on proximal
increased CD40 expression on thymic epithelial cells andtubular epithelial cells
endothelial cells, but not on synoviocytes or keratino-
Previously, we demonstrated the expression of CD40 cytes [40, 41, 47, 48]. Finally, it was recently demon-
on cultured PTECs [13]. In these experiments, we inves- strated that CD40L stimulation of smooth muscle and
tigated the effect of stimulation of PTECs with IL-1 endothelial cells activates IL-1b–converting enzyme
on the expression of CD40 as a possible mechanism to (ICE; caspase-1) and thus increases the generation of
explain the synergy between IL-1 and CD40L. Incuba- bioactive IL-1 [49]. In conclusion, these results show
tion of PTECs with IL-1a for 48 hours resulted in a 2.9- that IL-1 and CD40L are interacting with each other at
fold increase of CD40 expression (mean of five indepen- different levels of regulation and that these effects are
dent experiments, range 2.3 to 5.6; Fig. 8). These data different for specific cell types.
suggest that local inflammation may exert a direct effect Currently, the mechanism(s) behind the synergy be-
on CD40–CD40L interactions by up-regulation of CD40 tween IL-1 and CD40L remains unexplained. Although
a positive effect of IL-1 on CD40 expression is observed,on PTECs.
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Fig. 7. Polymerase chain reaction (PCR)
analysis of IL-1a and IL-1b expression in cul-
tured PTECs. Total RNA was isolated from
cultured PTECs, reverse transcribed, and
PCR for b-actin, IL-1a, and IL-1b was per-
formed. Shown is the ethidium bromide stain-
ing of PCR products analyzed on a 1% agarose
gel. (A) Semiquantitative analysis of the
amount of cDNA obtained either from non-
stimulated PTECs or from PTECs stimulated
with CD40L. Titration of the cDNA demon-
strates equal expression of b-actin in both cases.
(B) Expression of both IL-1a and IL-1b in
PTECs either nonstimulated (ns) or after
CD40L stimulation. H20 shows the negative
control of the PCR reaction.
it remains to be established whether this increased ex-
pression (which is already high in the absence of IL-1)
contributes to the higher cytokine production by PTECs.
It is probably more likely that different signal transduc-
tion pathways are converging intracellularly. Although
several intracellular signals transduced via IL-1 receptors
and CD40 have been described, no specific information
is available on signaling in tubular epithelial cells.
The important role of PTECs as a source of inflamma-
tory mediators (cytokines and chemokines) is widely ac-
cepted. Using our in vitro culture system, we found dis-
tinct differences in the regulation of the different
cytokines produced by PTECs. The production of MCP-
1 showed only additive effects between IL-1 and CD40L
compared with the synergistic effects on the production
of the other factors. RANTES production was strictly
Fig. 8. Interleukin-1 (IL-1) increases CD40 expression on PTECs.dependent on CD40 signaling or on combinations of
PTECs were cultured as described, in the absence or presence of IL-1
cytokines [29], whereas other factors were already pro- stimulation (1 ng/ml). After 48 hours, cells were harvested with EDTA
and stained for CD40 (mAb89). Staining was developed with a goat-duced under basal conditions. In addition, IL-4 specifi-
antimouse-PE conjugate and compared with an irrelevant antibodycally showed an effect on RANTES production and not
(represented by the dotted line). The histogram of the cells cultured
on the other factors. Finally, in our experiments, the in medium is left open, whereas the histogram of the cells stimulated
with IL-1 is filled.regulation of IL-6 and IL-8 production appeared to be
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similar. However, previous studies have demonstrated has been suggested. Increased expression of IL-1 in the
kidney has been demonstrated in various forms of glo-that IL-8 production, but not IL-6 production, is inhib-
ited by IFN-g [9, 11, 31]. Therefore, these data clearly merulonephritis [20–24]. Increased expression of IL-1
was also found in mice with lupus nephritis [58]. Immu-indicate that, at least in vitro, the production of cytokines
and chemokines by PTECs is regulated and fine tuned nohistochemistry showed that both infiltrating cells and
resident kidney cells, including tubular epithelial cells,by the presence of local cytokines.
Several lines of investigation have demonstrated that contribute to the increased IL-1 production. It has been
demonstrated that anti-glomerular basement membranethe ligand for CD40 (CD40L) is mainly expressed on
activated CD41 T cells, and plays a pivotal role in B-cell nephritis in rats can be aggravated by injection of IL-
1, whereas it can be inhibited by passive immunizationactivation and the development of humoral immune re-
sponses [33]. More recently, it has become clear that against IL-1b [59, 60]. In addition, treatment with a re-
combinant form of the natural IL-1RA was also shownCD40 might also play an important role in the activation
of other hematopoietic (monocytes, dendritic cells) and to blunt the inflammatory processes in experimental
forms of glomerulonephritis [25–27, 61].nonhematopoietic (endothelial cells and fibroblasts) cell
types. The functional consequence of CD40 activation In conclusion, we have demonstrated that combina-
tions of IL-1 and CD40L exert a very strong activationon these cells is diverse and includes enhanced survival,
phenotypic changes, expression of adhesion and costimu- of cytokine and chemokine production by PTECs. The
presence of IL-1, CD40L, and CD40 has been demon-latory molecules and the induced/enhanced production
of different cytokines [28, 50]. strated in various forms of renal inflammation, including
allograft rejection. This suggests an important role forUsing FACS analysis, strong and homogeneous ex-
pression of CD40 could be demonstrated on in vitro these proinflammatory signals in the regulation of local
inflammation. The inhibition of either the IL-1 pathwaycultured human PTECs [13]. In contrast, in normal kid-
neys, the expression of CD40 is restricted to a limited or the CD40L pathway has the potential to blunt the
inflammatory response. Future experiments should benumber of tubules, which can be both of distal and proxi-
mal origin [13, 51, 52]. However, CD40 expression is aimed at combining the targeting of these pathways in
experimental forms of inflammatory kidney diseases, toincreased on tubular epithelial cells under inflammatory
conditions. In line with this, we found an increased ex- establish whether the observed synergy between IL-1
and CD40L in vitro translates into enhanced inflamma-pression of CD40 on PTECs after IL-1 stimulation. This
suggests that the expression of CD40 on tubular epithe- tion in vivo.
lial cells is subject to regulatory mechanisms.
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